DOCSLIB.ORG

Osmotic Stress Response in the Industrially Important Bacterium

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Osmotic stress response in the industrially important bacterium Gluconobacter oxydans Dissertation to obtain the degree of Doctorate (Dr. rer. nat.) from the Faculty of Mathematics and Natural Sciences of the Rheinische Friedrich-Wilhelms University of Bonn, Germany submitted by Nageena Zahid from Lahore, Pakistan Bonn, November 2016 Finalized with the permission from the Faculty of Mathematics and Natural Sciences of the Rheinische Friedrich-Wilhelms University of Bonn, Germany First Referee: Prof. Dr. Uwe Deppenmeier Second Referee: Prof. Dr. Erwin A. Galinski Day of Promotion: 07.02.2017 Year of Publication: 2017 List of parts of this thesis that have already been published. Zahid N., Schweiger P., Galinski E., Deppenmeier U. (2015). Identification of mannitol as compatible solute in Gluconobacter oxydans. Appl Microbiol Biotechnol 99, 5511- 5521. Zahid N. and Deppenmeier U. (2016). Role of mannitol dehydrogenases in osmoprotection of Gluconobacter oxydans. Appl Microbiol Biotechnol 100, 9967-9978. For my Son TABLE OF CONTENTS 1. INTRODUCTION 1 1.1. Acetic acid bacteria 1 1.2. The genus Gluconobacter 2 1.2.1. Respiratory chain of G. oxydans 3 1.2.2. Intracellular carbohydrate metabolism in G. oxydans 6 1.2.3. Types and function of sugars and polyols metabolizing enzymes in Gluconobacter 7 1.2.4. Biotechnological applications of G. oxydans and its limitations 8 1.3. Aims of the work 10 2. MATERIALS AND METHODS 12 2.1. Chemicals and Enzymes 12 2.2. Bacterial strains, plasmids, primers 12 2.2.1. Bacterial strains 12 2.2.2. Oligonucleotides and Plasmids 13 2.3. Antibiotic stock solutions 18 2.4. Microbiology methods 18 2.4.1. Media and culture conditions 18 2.4.2. Measurement of osmolalities of growth media 22 2.4.3. Measurement of growth parameters 22 2.4.4. Preparation of stock cultures 23 2.5. Molecular biology methods 23 2.5.1. Isolation and purification of DNA 23 2.5.2. Isolation and purification of plasmid DNA 23 2.5.3. Isolation and purification of RNA 24 2.5.3.1. RNA extraction using the Trizol reagent method 24 2.5.3.2. RNA extraction with the Ribopure-Bacterial Kit 24 2.5.4. Spectrophotometric quantifications of DNA and RNA samples 25 2.5.5. Restriction digestion of DNA 25 2.5.6. Ligation 26 v 2.5.7. Polymerase chain reaction (PCR) 26 2.5.8. Reverse transcription quantitative PCR (RT-qPCR) 27 2.5.9. Agarose gel electrophoresis 28 2.5.10. Denaturing agarose gel electrophoresis 29 2.5.11. Staining of agarose gels 29 2.5.12. Evaluation of RNA integrity with Bioanalyzer 29 2.5.13. DNA sequencing 30 2.5.14. Illumina Next Generation Sequencing (NGS) and data analysis 30 2.5.15. Transformation of E. coli and G. oxydans 32 2.5.16. Generation of G. oxydans strains carrying in-frame deletions 33 2.5.17. Plasmid-based expression of genes 35 2.6. Biochemical methods 35 2.6.1. Protein overproduction and purification 35 2.6.1.1. Heterologous overproduction of proteins in E. coli 35 2.6.1.2. Heterologous overproduction of proteins in G. oxydans 36 2.6.1.3. Cell disruption and extraction of crude cell extract 36 2.6.1.4. Protein purification by Strep-Tactin Affinity chromatography 36 2.6.2. Extraction of cell cytoplasm 37 2.6.3. Quantification of protein concentration 37 2.6.4. PolyAcrylamide Gel Electrophoresis (PAGE) 38 2.6.4.1. Sodium Dodecyl Sulphate PolyAcrylamide Gel Electrophoresis 38 2.6.4.2. Native PAGE 38 2.6.5. Silver staining 39 2.6.6. Immunoblot 39 2.6.7. Activity staining 40 2.6.8. Determination of enzymatic activities 41 2.6.8.1. Measurement of activities of NAD(P)H dependent oxidoreductases 41 2.6.8.2. Glucose isomerase: enzyme assay with auxillary enzymes 43 2.7. Analytical methods 44 2.7.1. Sample preparation for the determination of intracellular solutes 44 2.7.2. High Performance Liquid Chromatography 45 2.7.3. Photometric determination of glucose and fructose concentration 46 2.7.4. 13C-Nuclear magnetic resonance spectroscopy 46 vi 2.7.5. Microscopy 47 2.8. Internet tools used for bioinformatic analysis 47 3. RESULTS 49 3.1 Osmotic stress responses in G. oxydans 50 3.1.1. Choice of substrate and osmolyte 50 3.1.2. Expression studies of osmotically regulated genes in G. oxydans 52 3.1.3. Analysis of osmotic stress responses in G. oxydans through genome-wide transcriptome analysis 54 3.1.3.1. Quality testing of RNA samples 55 3.1.3.2. Differential gene expression under osmotic stress analyzed by transcriptome sequencing 57 3.1.3.3. Validation of the transcriptome data and selection of candidate genes 63 3.1.3.4. Generation of G. oxydans strains carrying in-frame deletions for gox1118 and gox1119 64 3.1.3.5. Characterization of Gox1849: an uncharacterized oxidoreductase 68 3.2. Mannitol as a major intracellular metabolite and osmolyte in G. oxydans 70 3.2.1. 13C-NMR spectroscopy of total cellular metabolites from G. oxydans 70 3.2.2. Effect of mannitol on cellular catalytic activity 72 3.2.3. De novo synthesis of mannitol in G. oxydans under reduced water activity 74 3.2.4. Effect of carbon sources and osmolytes on mannitol accumulation 79 3.2.5. Effect of exogenous mannitol on growth and morphology of osmotically stressed cells 80 3.2.6. Effect of polyols on growth and substrate oxidation rates of G. oxydans 83 3.3. Enzymatic routes for the biosynthesis of mannitol in G. oxydans 84 3.3.1. Identification and bioinformatic analysis of the mannitol dehydrogenases from G. oxydans 85 3.3.2. Characterization of the mannitol dehydrogenases from G. oxydans 87 3.3.3. Transcript abundance of genes coding for D-fructose reductases in G. oxydans 91 3.3.4. Characterization of fructose reductase deletion mutants 92 3.3.4.1. Effect of the deletion of fructose reductases on growth of G. oxydans 92 3.3.4.2. Intracellular mannitol formation and activity of cytoplasmic fructose reductases 97 vii 3.3.4.3. Effect of the deletion of fructose reductases on cellular catalytic efficiency 101 3.4. Metabolic engineering of G. oxydans for enhanced osmotolerance 102 3.4.1. Overproduction of D-fructose reductase (Gox1432) in G. oxydans 103 3.4.2. Heterologous overproduction of glucose isomerases in G. oxydans 104 4. DISCUSSION 108 4.1. Osmotic stress responses in G. oxydans 111 4.1.2. Response of G. oxydans to osmotic stress at transcriptional level 113 4.1.3. Genome-wide transcriptome analysis of osmotically stressed cells of G. oxydans 113 4.2. Mannitol as a major intracellular metabolite and osmolyte in G. oxydans 116 4.2.1. De novo synthesis of mannitol in G. oxydans under reduced water activity 118 4.2.2. Osmodependent accumulation of mannitol in G. oxydans 119 4.2.3. Effect of carbon sources and osmolytes on mannitol accumulation in G.oxydans 120 4.2.4. Protective effect of mannitol on cell physiology 121 4.2.5. Effect of polyols on growth and substrate oxidation rates of G. oxydans 125 4.3. Biosynthesis of mannitol in G. oxydans 126 4.4. Characterization of the relative contribution of Gox1432 and Gox0849 in cellular osmoprotection 131 4.5. Characterization of fructose reductase deletion mutants 133 4.6. Metabolic engineering of G. oxydans for enhanced osmotolerance 134 4.6.1. Overproduction of D-fructose reductase (Gox1432) 135 4.6.2. Heterologous overproduction of glucose isomerases in G. oxydans 136 4.7. Gox1432: key player for osmotolerance of G. oxydans 138 5. SUMMARY 140 6. REFERENCES 142 7. CURRICULUM VITAE 165 8. ACKNOWLEDGEMENTS 167 viii ABBREVIATION LIST ACN Acetonitrile ADP Adenosine diphosphate α Alpha Amp Ampicillin APS Ammonium persulfate ATP Adenosine triphosphate BLAST Basic Local Alignment Search Tool bp Base pair β Beta cDNA Complementary DNA cdw Cell dry weight oC Degree centigrade δ Chemical shift ddH2O Double distilled water DMSO Dimethyl sulfoxide DNase Deoxyribonuclease dNTP Desoxyribonucleotide triphosphate DSMZ German Collection of Microorganisms and Cell cultures e.g., exempli gratia (For example) EDP Entner-Doudoroff pathway EDTA Ethylenediaminetetraacetic acid EMP Embden-Meyerhof-Parnas glycolytic pathway et al. et alii (and others) FAD Flavin adenine dinucleotide 5-FC 5-fluorocytosine For Forward g Gravitational acceleration (9.8 m/s2) GI Glucose isomerase Gox Gluconobacter oxydans h Hour H2O2 Hydrogen peroxide H2Odest Destillata (Distilled water) H2SO4 Sulfuric acid HABA 4-hydroxyazobenzen-2-carbonic acid HCl Hydrogen chloride HEPES 2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethanesulfonic acid HPLC High performance liquid chromatography Km Kanamycin kb Kilobase Kcat Turnover number kDa Kilodalton KEGG Kyoto Encyclopedia of Genes and Genomes kg Kilogram KM Michaelis Menten constant K-phosphate Potassium phosphate LB Lysogeny broth M Molar (mol L-1) mbar Millibar ix Mbp Megabase pair MDH Mannitol dehydrogenase MgCl2 Magnesium chloride MgSO4 Magnesium sulphate µ Micro min Minute MOPS 3-(N-morpholino)-propansulfonic acid mRNA Messenger RNA ms Millisecond NaCl Sodium chloride NAD+ Nicotinamide adenine dinucleotide NADP+ Nicotinamide adenine dinucleotide phosphate NCBI National Center for Biotechnology information ng Nanogram NGS Next generation sequencing NMR Nuclear magnetic resonance OD Optical density Osm Number of osmoles ox. PPP Oxidative pentose phosphate pathway P Phosphate PAGE Polyacrylamide gel electrophoresis PCR Polymerase chain reaction PEG Polyethylene glycol % Percent (grams per 100 mL or mL per 100 mL) pg Picogram Pi Inorganic phosphate PPP Pentose phosphate pathway PQQ Pyrroloquinoline quinone R2 The Pearson correlation coefficient of determination rev Reverse rpm Revolutions per minute RNA-Seq RNA sequencing RPKM Reads Per Kilobase of transcript per Million mapped reads rRNA Ribosomal RNA RT-qPCR Real Time quantitative reverse transcription PCR SDS Sodium dodecyl sulphate SOC Super optimal broth with catabolite repression sp.
Recommended publications
  • Solarbio Catalogue with PRICES

    Solarbio Catalogue with PRICES

    CAS Name Grade Purity Biochemical Reagent Biochemical Reagent 75621-03-3 C8390-1 3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonateCHAPS Ultra Pure Grade 1g 75621-03-3 C8390-5 3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonateCHAPS 5g 57-09-0 C8440-25 Cetyl-trimethyl Ammonium Bromide CTAB High Pure Grade ≥99.0% 25g 57-09-0 C8440-100 Cetyl-trimethyl Ammonium Bromide CTAB High Pure Grade ≥99.0% 100g 57-09-0 C8440-500 Cetyl-trimethyl Ammonium Bromide CTAB High Pure Grade ≥99.0% 500g E1170-100 0.5M EDTA (PH8.0) 100ml E1170-500 0.5M EDTA (PH8.0) 500ml 6381-92-6 E8030-100 EDTA disodium salt dihydrate EDTA Na2 Biotechnology Grade ≥99.0% 100g 6381-92-6 E8030-500 EDTA disodium salt dihydrate EDTA Na2 Biotechnology Grade ≥99.0% 500g 6381-92-6 E8030-1000 EDTA disodium salt dihydrate EDTA Na2 Biotechnology Grade ≥99.0% 1kg 6381-92-6 E8030-5000 EDTA disodium salt dihydrate EDTA Na2 Biotechnology Grade ≥99.0% 5kg 60-00-4 E8040-100 Ethylenediaminetetraacetic acid EDTA Ultra Pure Grade ≥99.5% 100g 60-00-4 E8040-500 Ethylenediaminetetraacetic acid EDTA Ultra Pure Grade ≥99.5% 500g 60-00-4 E8040-1000 Ethylenediaminetetraacetic acid EDTA Ultra Pure Grade ≥99.5% 1kg 67-42-5 E8050-5 Ethylene glycol-bis(2-aminoethylether)-N,N,NEGTA′,N′-tetraacetic acid Ultra Pure Grade ≥97.0% 5g 67-42-5 E8050-10 Ethylene glycol-bis(2-aminoethylether)-N,N,NEGTA′,N′-tetraacetic acid Ultra Pure Grade ≥97.0% 10g 50-01-1 G8070-100 Guanidine Hydrochloride Guanidine HCl ≥98.0%(AT) 100g 50-01-1 G8070-500 Guanidine Hydrochloride Guanidine HCl ≥98.0%(AT) 500g 56-81-5
  • Fungal Pathogenesis in Humans the Growing Threat

    Fungal Pathogenesis in Humans the Growing Threat

    Fungal Pathogenesis in Humans The Growing Threat Edited by Fernando Leal Printed Edition of the Special Issue Published in Genes www.mdpi.com/journal/genes Fungal Pathogenesis in Humans Fungal Pathogenesis in Humans The Growing Threat Special Issue Editor Fernando Leal MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Fernando Leal Instituto de Biolog´ıa Funcional y Genomica/Universidad´ de Salamanca Spain Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Genes (ISSN 2073-4425) from 2018 to 2019 (available at: https://www.mdpi.com/journal/genes/special issues/Fungal Pathogenesis Humans Growing Threat). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-900-5 (Pbk) ISBN 978-3-03897-901-2 (PDF) Cover image courtesy of Fernando Leal. c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Fernando Leal Special Issue: Fungal Pathogenesis in Humans: The Growing Threat Reprinted from: Genes 2019, 10, 136, doi:10.3390/genes10020136 ..................
  • Transcriptome Profiling of the Rice Blast Fungus During Invasive Plant

    Transcriptome Profiling of the Rice Blast Fungus During Invasive Plant

    Mathioni et al. BMC Genomics 2011, 12:49 http://www.biomedcentral.com/1471-2164/12/49 RESEARCHARTICLE Open Access Transcriptome profiling of the rice blast fungus during invasive plant infection and in vitro stresses Sandra M Mathioni1, André Beló1, Christopher J Rizzo2, Ralph A Dean3, Nicole M Donofrio1* Abstract Background: Rice blast is the most threatening disease to cultivated rice. Magnaporthe oryzae, its causal agent, is likely to encounter environmental challenges during invasive growth in its host plants that require shifts in gene expression to establish a compatible interaction. Here, we tested the hypothesis that gene expression patterns during in planta invasive growth are similar to in vitro stress conditions, such as nutrient limitation, temperature up shift and oxidative stress, and determined which condition most closely mimicked that of in planta invasive growth. Gene expression data were collected from these in vitro experiments and compared to fungal gene expression during the invasive growth phase at 72 hours post-inoculation in compatible interactions on two grass hosts, rice and barley. Results: We identified 4,973 genes that were differentially expressed in at least one of the in planta and in vitro stress conditions when compared to fungal mycelia grown in complete medium, which was used as reference. From those genes, 1,909 showed similar expression patterns between at least one of the in vitro stresses and rice and/or barley. Hierarchical clustering of these 1,909 genes showed three major clusters in which in planta conditions closely grouped with the nutrient starvation conditions. Out of these 1,909 genes, 55 genes and 129 genes were induced and repressed in all treatments, respectively.
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System

    All Enzymes in BRENDA™ the Comprehensive Enzyme Information System

    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
  • Biocatalysis and Pharmaceuticals a Smart Tool for Sustainable Development

    Biocatalysis and Pharmaceuticals a Smart Tool for Sustainable Development

    catalysts Biocatalysis and Pharmaceuticals A Smart Tool for Sustainable Development Edited by Andrés R. Alcàntara Printed Edition of the Special Issue Published in Catalysts www.mdpi.com/journal/catalysts Biocatalysis and Pharmaceuticals Biocatalysis and Pharmaceuticals A Smart Tool for Sustainable Development Special Issue Editor Andr´es R. Alc´antara MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Andres´ R. Alcantara´ Complutense University Spain Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Catalysts (ISSN 2073-4344) from 2018 to 2019 (available at: https://www.mdpi.com/journal/catalysts/special issues/biocatalysis pharmaceuticals). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03921-708-3 (Pbk) ISBN 978-3-03921-709-0 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Andr´esR. Alc´antara Biocatalysis and Pharmaceuticals: A Smart Tool for Sustainable Development Reprinted from: Catalysts 2019, 9, 792, doi:10.3390/catal9100792 ..................
  • Springer Handbook of Enzymes

    Springer Handbook of Enzymes

    Dietmar Schomburg Ida Schomburg (Eds.) Springer Handbook of Enzymes Alphabetical Name Index 1 23 © Springer-Verlag Berlin Heidelberg New York 2010 This work is subject to copyright. All rights reserved, whether in whole or part of the material con- cerned, specifically the right of translation, printing and reprinting, reproduction and storage in data- bases. The publisher cannot assume any legal responsibility for given data. Commercial distribution is only permitted with the publishers written consent. Springer Handbook of Enzymes, Vols. 1–39 + Supplements 1–7, Name Index 2.4.1.60 abequosyltransferase, Vol. 31, p. 468 2.7.1.157 N-acetylgalactosamine kinase, Vol. S2, p. 268 4.2.3.18 abietadiene synthase, Vol. S7,p.276 3.1.6.12 N-acetylgalactosamine-4-sulfatase, Vol. 11, p. 300 1.14.13.93 (+)-abscisic acid 8’-hydroxylase, Vol. S1, p. 602 3.1.6.4 N-acetylgalactosamine-6-sulfatase, Vol. 11, p. 267 1.2.3.14 abscisic-aldehyde oxidase, Vol. S1, p. 176 3.2.1.49 a-N-acetylgalactosaminidase, Vol. 13,p.10 1.2.1.10 acetaldehyde dehydrogenase (acetylating), Vol. 20, 3.2.1.53 b-N-acetylgalactosaminidase, Vol. 13,p.91 p. 115 2.4.99.3 a-N-acetylgalactosaminide a-2,6-sialyltransferase, 3.5.1.63 4-acetamidobutyrate deacetylase, Vol. 14,p.528 Vol. 33,p.335 3.5.1.51 4-acetamidobutyryl-CoA deacetylase, Vol. 14, 2.4.1.147 acetylgalactosaminyl-O-glycosyl-glycoprotein b- p. 482 1,3-N-acetylglucosaminyltransferase, Vol. 32, 3.5.1.29 2-(acetamidomethylene)succinate hydrolase, p. 287 Vol.
  • Comprehensive Metabolomic Study of the Response of HK-2 Cells to Hyperglycemic, Hypoxic Diabetic-Like Milieu Has Never Been Performed

    Comprehensive Metabolomic Study of the Response of HK-2 Cells to Hyperglycemic, Hypoxic Diabetic-Like Milieu Has Never Been Performed

    www.nature.com/scientificreports OPEN Comprehensive metabolomic study of the response of HK‑2 cells to hyperglycemic hypoxic diabetic‑like milieu Alberto Valdés 1,2*, Francisco J. Lucio‑Cazaña3, María Castro‑Puyana1,4, Coral García‑Pastor3, Oliver Fiehn2 & María Luisa Marina 1,4* Diabetic nephropathy (DN) is the leading cause of chronic kidney disease. Although hyperglycaemia has been determined as the most important risk factor, hypoxia also plays a relevant role in the development of this disease. In this work, a comprehensive metabolomic study of the response of HK‑2 cells, a human cell line derived from normal proximal tubular epithelial cells, to hyperglycemic, hypoxic diabetic‑like milieu has been performed. Cells simultaneously exposed to high glucose (25 mM) and hypoxia (1% O2) were compared to cells in control conditions (5.5 mM glucose/18.6% O2) at 48 h. The combination of advanced metabolomic platforms (GC‑TOF MS, HILIC‑ and CSH‑ QExactive MS/MS), freely available metabolite annotation tools, novel databases and libraries, and stringent cut‑of flters allowed the annotation of 733 metabolites intracellularly and 290 compounds in the extracellular medium. Advanced bioinformatics and statistical tools demonstrated that several pathways were signifcantly altered, including carbohydrate and pentose phosphate pathways, as well as arginine and proline metabolism. Other afected metabolites were found in purine and lipid metabolism, the protection against the osmotic stress and the prevention of the activation of the β‑oxidation pathway. Overall, the efects of the combined exposure of HK‑cells to high glucose and hypoxia are reasonably compatible with previous in vivo works. Diabetic nephropathy (DN) is the leading cause of chronic kidney disease and if afects approximately 25–40% of type 1 and type 2 diabetic patients 1,2.
  • Genome-Scale Metabolic Model of the Human Pathogen Candida Albicans: a Promising Platform for Drug Target Prediction

    Genome-Scale Metabolic Model of the Human Pathogen Candida Albicans: a Promising Platform for Drug Target Prediction

    Journal of Fungi Article Genome-Scale Metabolic Model of the Human Pathogen Candida albicans: A Promising Platform for Drug Target Prediction Romeu Viana 1,2, Oscar Dias 3 , Davide Lagoa 3,Mónica Galocha 1,2, Isabel Rocha 3,4,* and Miguel Cacho Teixeira 1,2,* 1 Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisbon, Portugal; [email protected] (R.V.); [email protected] (M.G.) 2 Institute for Bioengineering and Biosciences, Biological Sciences Research Group, Instituto Superior Técnico, 1049-001 Lisbon, Portugal 3 Centre of Biological Engineering, Universidade do Minho, 4710-057 Braga, Portugal; [email protected] (O.D.); [email protected] (D.L.) 4 Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB-NOVA), 2780-157 Oeiras, Portugal * Correspondence: [email protected] (I.R.); [email protected] (M.C.T.) Received: 27 July 2020; Accepted: 8 September 2020; Published: 11 September 2020 Abstract: Candida albicans is one of the most impactful fungal pathogens and the most common cause of invasive candidiasis, which is associated with very high mortality rates. With the rise in the frequency of multidrug-resistant clinical isolates, the identification of new drug targets and new drugs is crucial in overcoming the increase in therapeutic failure. In this study, the first validated genome-scale metabolic model for Candida albicans, iRV781, is presented. The model consists of 1221 reactions, 926 metabolites, 781 genes, and four compartments. This model was reconstructed using the open-source software tool merlin 4.0.2. It is provided in the well-established systems biology markup language (SBML) format, thus, being usable in most metabolic engineering platforms, such as OptFlux or COBRA.
  • 634238V1.Full.Pdf

    634238V1.Full.Pdf

    bioRxiv preprint doi: https://doi.org/10.1101/634238; this version posted May 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Identification of NAD-dependent xylitol dehydrogenase from Gluconobacter 2 oxydans WSH-003 3 4 Li Liu1,2,4, Weizhu Zeng1, Guocheng Du1,3, Jian Chen1,2,4, Jingwen Zhou1,2,4* 5 6 1 School of Biotechnology and Key Laboratory of Industrial Biotechnology, Ministry 7 of Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China. 8 2 National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan 9 University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China. 10 3 The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of 11 Education, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China. 12 4 Jiangsu Provisional Research Center for Bioactive Product Processing Technology, 13 Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China. 14 15 * Corresponding author: Jingwen Zhou 16 Mailing address: School of Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, 17 Jiangsu 214122, China 18 Phone: +86-510-85914317, Fax: +86-510-85914317 19 E-mail: [email protected]. 20 21 bioRxiv preprint doi: https://doi.org/10.1101/634238; this version posted May 10, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy

    Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy

    H OH metabolites OH Review Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy Diren Beyo˘gluand Jeffrey R. Idle * Arthur G. Zupko’s Division of Systems Pharmacology and Pharmacogenomics, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 Dekalb Avenue, Brooklyn, NY 11201, USA; [email protected] * Correspondence: jeff[email protected] Received: 13 January 2020; Accepted: 26 January 2020; Published: 28 January 2020 Abstract: In recent years, there has been a plethora of attempts to discover biomarkers that are more reliable than α-fetoprotein for the early prediction and prognosis of hepatocellular carcinoma (HCC). Efforts have involved such fields as genomics, transcriptomics, epigenetics, microRNA, exosomes, proteomics, glycoproteomics, and metabolomics. HCC arises against a background of inflammation, steatosis, and cirrhosis, due mainly to hepatic insults caused by alcohol abuse, hepatitis B and C virus infection, adiposity, and diabetes. Metabolomics offers an opportunity, without recourse to liver biopsy, to discover biomarkers for premalignant liver disease, thereby alerting the potential of impending HCC. We have reviewed metabolomic studies in alcoholic liver disease (ALD), cholestasis, fibrosis, cirrhosis, nonalcoholic fatty liver (NAFL), and nonalcoholic steatohepatitis (NASH). Specificity was our major criterion in proposing clinical evaluation of indole-3-lactic acid, phenyllactic acid, N-lauroylglycine, decatrienoate, N-acetyltaurine for ALD, urinary sulfated bile acids for cholestasis, cervonoyl ethanolamide for fibrosis, 16α-hydroxyestrone for cirrhosis, and the pattern of acyl carnitines for NAFL and NASH. These examples derive from a large body of published metabolomic observations in various liver diseases in adults, adolescents, and children, together with animal models.
  • US 2020/0078401 A1 VIJAYANAND Et Al

    US 2020/0078401 A1 VIJAYANAND Et Al

    US 20200078401A1 IN ( 19 ) United States (12 ) Patent Application Publication ( 10) Pub . No .: US 2020/0078401 A1 VIJAYANAND et al. (43 ) Pub . Date : Mar. 12 , 2020 (54 ) COMPOSITIONS FOR CANCER (52 ) U.S. CI. TREATMENT AND METHODS AND USES CPC A61K 35/17 ( 2013.01) ; A61K 45/06 FOR CANCER TREATMENT AND ( 2013.01 ) ; C120 1/6886 ( 2013.01 ) ; A61P PROGNOSIS 35/00 (2018.01 ) ( 71 ) Applicants : La Jolla Institute for Allergy and Immunology , La Jolla , CA (US ) ; UNIVERSITY OF SOUTHAMPTON , (57 ) ABSTRACT Hampshire (GB ) (72 ) Inventors : Pandurangan VIJAYANAND , La Jolla , CA (US ) ; Christian Global transcriptional profiling of CTLs in tumors and OTTENSMEIER , Hampshire (GB ) ; adjacent non -tumor tissue from treatment- naive patients Anusha PreethiGANESAN , La Jolla , with early stage lung cancer revealed molecular features CA (US ) ; James CLARKE , Hampshire associated with robustness of anti - tumor immune responses . (GB ) ; Tilman SANCHEZ - ELSNER , Major differences in the transcriptional program of tumor Hampshire (GB ) infiltrating CTLswere observed that are shared across tumor subtypes . Pathway analysis revealed enrichment of genes in ( 21 ) Appl. No .: 16 / 465,983 cell cycle , T cell receptor ( TCR ) activation and co -stimula tion pathways , indicating tumor- driven expansion of pre ( 22 ) PCT Filed : Dec. 7 , 2017 sumed tumor antigen - specific CTLs. Marked heterogeneity in the expression ofmolecules associated with TCR activa ( 86 ) PCT No .: PCT /US2017 / 065197 tion and immune checkpoints such as 4-1BB , PD1, TIM3, $ 371 ( c ) ( 1 ) , was also observed and their expression was positively ( 2 ) Date : May 31 , 2019 correlated with the density of tumor- infiltrating CTLs. Tran scripts linked to tissue- resident memory cells ( TRM ), such Related U.S.
  • Studies on Central Carbon Metabolism and Respiration of Gluconobacter Oxydans 621H

    Studies on Central Carbon Metabolism and Respiration of Gluconobacter Oxydans 621H

    Studies on central carbon metabolism and respiration of Gluconobacter oxydans 621H Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf vorgelegt von Tanja Hanke aus Solingen Düsseldorf, Dezember 2009 Aus dem Institut für Biotechnologie 1 des Forschungszentrums Jülich GmbH Gedruckt mit der Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Heinrich-Heine-Universität Düsseldorf Referent: Prof. Dr. H. Sahm Koreferent: Prof. Dr. M. Bott Tag der mündlichen Prüfung: 22.01.2010 Publications Hanke T, Noack S, Nöh K, Bringer S, Oldiges M, Sahm H, Bott M, Wiechert W (2010) Characterisation of glucose catabolism in Gluconobacter oxydans 621H by 13C- labeling and metabolic flux analysis. Submitted to FEMS Microbiology Letters Hanke T, Bringer S, Polen T, Sahm H, Bott M (2010) Genome-wide microarray analyses of Gluconobacter oxydans: Response to oxygen depletion, growth phases and acidic growth conditions. Manuscript for submission to J Bacteriol Hanke T, Bringer S, Sahm H Bott M (2010) The cytochrome bc1 complex in Gluconobacter oxydans 621H: Functional analysis by fermentation studies and whole cell kinetics with a marker-free deletion mutant. Manuscript for submission to J Bacteriol Abstract Gluconobacter oxydans shows a number of exceptional characteristics, like the biphasic growth on glucose and the incomplete oxidation of glucose to gluconate (phase I, exponential growth,) and ketogluconates (phase II, linear growth), leading to an acidification of the medium down to pH values less than 4. Furthermore, growth and metabolism of G. oxydans is strongly dependent on the availability of oxygen. In the respiratory chain, two terminal end acceptors are present. The ubiquinol bd oxidase, preferably used under acidic pH, is less efficient in contribution to the proton motive force than the bo3 oxidase.